Abstract

The presented article is dedicated to the development of new procedure for quantitative voltammetric determination of cefotaxime powder for injection solution preparation in the form of corresponding S-oxide in weak acidic medium using potassium hydrogenperoxomonosulfate (KHSO5) as an analytical reagent. Voltammogramms of cefotaxime S-oxide solutions for different concentrations of cephalosporins were scanned. There are two peaks on the voltammetric curve of the cefotaxime S-oxide solution: at -0.65 V (that corresponds to potassium peroxomonosulfate) and -1.3 V (peak height was rising proportionally to cefotaxime concentrations increasing) that has been chosen as analytical. The calibration curve method can be easily applied. Linearity has been studied over a drug concentration range from 1·10-4 to 1·10-3 mol L-1. The correlation coefficient r=0.999. Precision and accuracy have been studied by analyzing five replicates of the sample solutions at three concentrations levels. The calculated relative standard deviations were below 1.75 %, d ≤ -1.1 % indicating excellent precision of the proposed procedure. The Limit of Detection (LOD) and the Limit of Quantification (LOQ) were calculated (LOD=1.2·10-5 mol L-1 and LOQ= 4·10-5 mol L-1). The proposed voltammetric method is sensitive enough, accurate, precise, replicable and linear to enable determination of lower amounts of drug. These advantages encourage the application of the method in routine quality control of cefotaxime in industrial laboratories.

Highlights

  • Cefotaxime (CFTM), which structure is presented in Scheme, is the second generation cephalosporin derivative widely used in clinical therapy of severe infections

  • Literature dealing with the electroactivity of cephalosporins and resulting analytical applications can be divided into two parts: papers concerning the direct polarographic activity of cephalosporins and papers dealing with polarography of their degradation products after intensive acidic, or alkaline hydrolysis [2,3,4, 7]

  • Cefotaxime is rapidly oxidisable to its sulfoxide in a quantitative yield by the excess of potassium peroxomonosulfate (KНSO5) (Scheme)

Read more

Summary

Introduction

Cefotaxime (CFTM), which structure is presented in Scheme, is the second generation cephalosporin derivative widely used in clinical therapy of severe infections. It is (6R,7R,Z)-3-(Acetoxymethyl)7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid [5]. The indirect method of determination of cephalosporins as the corresponding derivatives requires special conditions (heating, intensive alkali or acidic medium) and are long-lasting. It is supposed that the method of cephalosporin derivatives produced by S-oxidation reactions determination is more informative. Voltammetric determination of Cefotaxime by the reaction of S-oxidation by means of potassium peroxomonosulfate in a weak acidic medium was optimized and proposed for the first time

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call